SGLT-2 inhibitors reduce adverse CV events associated with restenosis in stents in patients with type 2 diabetes.

Published Date: 13 Mar 2023

Italy: Treatment with SGLT2 inhibitors in patients with type 2 diabetes (T2D) is associated with a reduced risk of restenosis in the stent...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

FDA Declines to Approve Achieve Life Sciences' Smoking-cessation Drug

2.

Uncovered biology underlies a novel drug used to treat triple-negative breast cancer.

3.

Chemotherapy damage to non-cancer cells may be the cause of breast cancer recurrence.

4.

Never in a million years did I think I'd have to limit my chemotherapy.

5.

Treating Depression: Crucial for Recovery From Fibromyalgia


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot